Thursday, July 25, 2013

See the new agenda for IBC’s 3rd Annual Cell Therapy Bioprocessing Conference!

The final agenda for IBC’s 3rd Annual Cell Therapy Bioprocessing Conference is now available. This year’s program provides a balance of product development strategies, process development and optimization methodologies, innovation case studies, product characterization, and bioprocessing/scale-up discussions with more contextual topics like industry overviews, CoGS cost modeling, and reimbursement.

Achieve commercial success with 20 case studies and new data presentations to help you:
  • - Scale Immunotherapies Using High- Throughput Technologies Throughput Technologies
  • - Streamline Manufacturing with Risk-Based, Unit Operation Approaches
  • - Quantify the Investment of Your Cell Therapies Using Cost of Goods Modeling
  • - Minimize Variation through Systematic Approaches to Process Design and Optimization
  • - Enhance Quality and Enable Process Changes with New Potency Evaluation Strategies
  • - Ensure Successful Scale Up and Validation by Establishing Process Consistency
  • - Reduce Risk in Cell Therapy Applications by Developing Serum-Free Reagents

Want to find out more about these case studies, the keynotes and the rest of the agenda?

The Cell Therapy Bioprocessing Event will take place October 21-22 in Bethesda, Maryalnd. As a reader of this blog, when you register to join us and mention code B13188JP20 and you’ll save 20% off the standard rate. Have any questions or want to get involved in this year’s event? Feel free to email Jennifer Pereira.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment